Wednesday, 27 December 2017

Targeting of EGFR increase anti-cancer effects of arsenic trioxide: promising treatment for glioblastoma multiform

From the European Journal of Pharmacology http://bit.ly/2lielsd
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)